clinical trials/ BE studies for locally acting drugs [Regulatives / Guidelines]

posted by jagankm  – 2012-02-06 13:00 (5239 d 18:42 ago) – Posting: # 8056
Views: 6,246

thank you for your response.

as per US FDA guidlines we have to conduct two BE studies both in fasting and fed conditions for sulfasalazine.
but we are in ambiguity to show BE for this molecule.

for docusate sodium, it is a solution in soft gelatin capsuls, as per the EMEA guidlines on locally acting liquids we may go for biowaivers.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
146 visitors (0 registered, 146 guests [including 23 identified bots]).
Forum time: 08:42 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5